Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRS NYSE:AUNA NASDAQ:VMD NASDAQ:XGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$5.35$3.97$1.51▼$12.00$377.42M2.31793,258 shs671,446 shsAUNAAuna$4.94-0.3%$5.01$4.09▼$6.85$366.36M0.81437,134 shs251,302 shsVMDViemed Healthcare$10.45+0.3%$9.66$5.93▼$10.68$399.47M1.12199,109 shs200,402 shsXGNExagen$4.67+4.2%$3.64$2.59▼$12.23$108.24M2.02401,624 shs145,515 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies0.00%+4.70%+14.81%+189.19%+4.70%AUNAAuna0.00%+11.65%+1.65%-2.91%-21.79%VMDViemed Healthcare+0.29%+4.81%+10.12%+13.59%+54.81%XGNExagen+4.24%+8.86%+34.58%+52.12%-35.67%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$5.35$3.97$1.51▼$12.00$377.42M2.31793,258 shs671,446 shsAUNAAuna$4.94-0.3%$5.01$4.09▼$6.85$366.36M0.81437,134 shs251,302 shsVMDViemed Healthcare$10.45+0.3%$9.66$5.93▼$10.68$399.47M1.12199,109 shs200,402 shsXGNExagen$4.67+4.2%$3.64$2.59▼$12.23$108.24M2.02401,624 shs145,515 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies0.00%+4.70%+14.81%+189.19%+4.70%AUNAAuna0.00%+11.65%+1.65%-2.91%-21.79%VMDViemed Healthcare+0.29%+4.81%+10.12%+13.59%+54.81%XGNExagen+4.24%+8.86%+34.58%+52.12%-35.67%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 1.50Reduce$4.50-15.89% DownsideAUNAAuna 2.40Hold$6.9741.17% UpsideVMDViemed Healthcare 2.00HoldN/AN/AXGNExagen 2.78Moderate Buy$9.2598.07% UpsideCurrent Analyst Ratings BreakdownLatest XGN, VMD, AIRS, and AUNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2026AIRSAirSculpt Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/26/2026AUNAAuna JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$6.00 ➝ $5.005/14/2026AIRSAirSculpt Technologies Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$4.505/12/2026XGNExagen Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/12/2026XGNExagen BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.004/27/2026XGNExagen Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/20/2026XGNExagen Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$10.00 ➝ $8.003/31/2026AUNAAuna Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/27/2026AUNAAuna Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)(Data available from 6/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$151.82M2.49$0.02 per share299.85$1.40 per share3.82AUNAAuna$1.23B0.30$1.95 per share2.53$6.70 per share0.74VMDViemed Healthcare$270.28M1.48$1.15 per share9.05$3.78 per share2.76XGNExagen$66.57M1.69N/AN/A$0.77 per share6.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$11.67M-$0.17N/AN/AN/A-7.39%-4.98%-2.36%8/7/2026 (Estimated)AUNAAuna$27.39M$0.2618.985.04N/A1.53%16.25%4.03%8/18/2026 (Estimated)VMDViemed Healthcare$14.93M$0.3728.2418.02N/A5.20%10.52%7.60%8/5/2026 (Estimated)XGNExagen-$19.95M-$0.89N/AN/AN/A-29.49%-94.37%-28.96%8/4/2026 (Estimated)Latest XGN, VMD, AIRS, and AUNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026AUNAAuna$0.19$0.0510-$0.1390$0.03$320.54 million$336.84 million5/11/2026Q1 2026XGNExagen-$0.24-$0.17+$0.07-$0.17$16.41 million$17.31 million5/8/2026Q4 2025AIRSAirSculpt Technologies-$0.02-$0.03-$0.01-$0.03$39.20 million$39.39 million5/5/2026Q1 2026VMDViemed Healthcare$0.09$0.06-$0.03$0.06$74.40 million$75.41 million3/31/2026Q4 2025AIRSAirSculpt Technologies-$0.02-$0.02N/A$0.02N/A$33.44 million3/31/2026Q4 2025AIRSAirSculpt Technologies-$0.03$0.02+$0.05$0.02$34.93 million$33.44 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/AAUNAAunaN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/AXGNExagenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.390.750.75AUNAAuna1.761.091.00VMDViemed Healthcare0.061.221.10XGNExagen1.673.473.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%AUNAAunaN/AVMDViemed Healthcare74.24%XGNExagen75.25%Insider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies44.60%AUNAAunaN/AVMDViemed Healthcare20.00%XGNExagen10.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24070.55 million39.08 millionOptionableAUNAAuna15,25474.01 millionN/AN/AVMDViemed Healthcare1,38238.34 million30.67 millionNot OptionableXGNExagen22024.16 million21.65 millionOptionableXGN, VMD, AIRS, and AUNA HeadlinesRecent News About These CompaniesExagen Shareholders Approve Directors, Auditor and Pay PackageJune 9, 2026 | tipranks.comExagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE LupusJune 1, 2026 | globenewswire.comHow Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%May 28, 2026 | zacks.comExagen Earnings Call Highlights Growth Amid Key RisksMay 15, 2026 | theglobeandmail.comThe Exagen Inc. (NASDAQ:XGN) First-Quarter Results Are Out And Analysts Have Published New ForecastsMay 15, 2026 | finance.yahoo.comExagen Inc. (NASDAQ:XGN) Q1 2026 Earnings Call TranscriptMay 13, 2026 | insidermonkey.comExagen Inc (XGN) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...May 12, 2026 | finance.yahoo.comExagen Inc. (XGN) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comRecord revenue growth and higher test pricing keep Exagen (XGN) in focus despite ongoing lossesMay 12, 2026 | msn.comExagen Inc. (XGN) Reports Q1 Loss, Beats Revenue EstimatesMay 11, 2026 | zacks.comExagen Inc. Reports First Quarter 2026 ResultsMay 11, 2026 | globenewswire.comZimmer Biomet (ZBH) Q1 Earnings and Revenues Top EstimatesApril 28, 2026 | zacks.comExagen Inc. to Announce First Quarter Financial Results on May 11, 2026April 27, 2026 | globenewswire.comExagen Announces Board Resignation and Committee RestructuringApril 23, 2026 | tipranks.comDoes Exagen (XGN)’s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode?April 12, 2026 | insidermonkey.comHow Analyst Resets Are Reshaping The Exagen (XGN) Investment StoryMarch 27, 2026 | finance.yahoo.comExagen (XGN) price target decreased by 21.78% to 10.03March 27, 2026 | msn.comExagen outlines $70M–$73M 2026 revenue target while expanding sales force and innovation cadenceMarch 11, 2026 | seekingalpha.comExagen Inc. (XGN) Q4 2025 Earnings Call TranscriptMarch 10, 2026 | seekingalpha.comExagen Inc (XGN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic InvestmentsMarch 10, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026AI Consolidation Begins: Blackstone & Google Forge an AI EmpireBy Jeffrey Neal Johnson | May 20, 2026Motorola's $1.5B Bet to Own the SkiesBy Jeffrey Neal Johnson | June 3, 2026Palo Alto Networks Accelerates Growth 31% on AI DemandBy Thomas Hughes | June 3, 2026XGN, VMD, AIRS, and AUNA Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$5.35 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$5.36 +0.01 (+0.09%) As of 06/12/2026 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.Auna NYSE:AUNA$4.93 -0.02 (-0.30%) Closing price 06/12/2026 03:59 PM EasternExtended Trading$4.89 -0.04 (-0.91%) As of 06/12/2026 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.Viemed Healthcare NASDAQ:VMD$10.45 +0.03 (+0.29%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$10.44 -0.01 (-0.13%) As of 06/12/2026 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.Exagen NASDAQ:XGN$4.67 +0.19 (+4.24%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$4.68 +0.00 (+0.11%) As of 06/12/2026 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
